Keyphrases
Ablative
14%
Androgen Receptor
100%
Androgen Receptor Expression
100%
Cell Viability
14%
Cyclin D1 (CCND1)
14%
Differential Susceptibility
14%
Discriminatory Effects
14%
Drug-induced
14%
High Dose
14%
High Potency
14%
Inhibitory Effect
14%
LNCaP
14%
LNCaP Cells
14%
MRNA Level
14%
Normal Prostate
14%
Peroxisome Proliferator-activated Receptor
100%
Peroxisome Proliferator-activated Receptor Agonists
14%
Pharmacologic
100%
Prostate Cancer Cells
14%
Prostate Epithelial Cells
14%
Prostate Tumorigenesis
14%
Proteasomal Degradation
14%
Protein Level
14%
Proteolysis
28%
Quantitative PCR
14%
Receptor Downregulation
14%
Receptor-independent
100%
Regulatory Proteins
14%
Reporter Gene Assay
14%
SiRNA Knockdown
14%
Structural Modification
14%
TATA-binding Protein
14%
Transcription Factor
14%
Transcriptional Repression
28%
Troglitazone
100%
Ubiquitin
14%
Ubiquitin-proteasome System
14%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Cancer Cell
9%
Carcinogenesis
9%
Cell Viability
9%
Cyclin D1
9%
Drug Megadose
9%
LNCaP
18%
Messenger RNA
9%
Peroxisome Proliferator-Activated Receptor
100%
PPAR Agonist
9%
Proteasome
9%
Protein Catabolism
18%
Receptor down Regulation
9%
Reporter Gene
9%
Reverse Transcription Polymerase Chain Reaction
9%
RNA Knockdown
9%
Small Interfering RNA
9%
TATA Binding Protein Associated Factor
9%
Transcription
9%
Troglitazone
100%
Ubiquitin
18%
Immunology and Microbiology
Agonist
25%
Cancer Cell
25%
Cell Viability
25%
Cyclin D1
25%
Drug Megadose
25%
Peroxisome
100%
Proteasome
25%
Protein Degradation
50%
Receptor down Regulation
25%
Reporter Gene
25%
Reverse Transcription Polymerase Chain Reaction
25%
RNA Knockdown
25%
TATA Binding Protein Associated Factor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Receptor
100%
Carcinogenesis
9%
Cell Viability
9%
Cyclin D1
9%
Messenger RNA
9%
Peroxisome Proliferator Activated Receptor
100%
PPAR Agonist
9%
Prostate Cancer
9%
Proteasome
9%
Regulator Protein
9%
Small Interfering RNA
9%
TATA Binding Protein Associated Factor
9%
Troglitazone
100%
Ubiquitin
18%